Hirano K, Nagae T, Adachi T, Ito Y, Sugiura M
J Pharmacobiodyn. 1983 Aug;6(8):588-94. doi: 10.1248/bpb1978.6.588.
A solid phase immunoassay for the determination of adriamycin has been developed. Specific antibody against adriamycin was raised in rabbits after coupling adriamycin to bovine serum albumin. beta-D-Galactosidase labelled adriamycin was prepared by m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) as a coupling reagent. This assay system followed the double antibody solid phase method for the B/F separation of antibody-bound and free adriamycin. By this method, from 0.5 to 100 ng of adriamycin could be detected. Using this assay system, drug levels were determined in serum of mice, following administration of adriamycin in a single dose of 15 mg/kg i.p., the peak appearing at 20 min after administration. The change of serum levels was found to be biphasic, and the half-life of beta-phase was about 5 h.
已开发出一种用于测定阿霉素的固相免疫测定法。将阿霉素与牛血清白蛋白偶联后,在兔体内产生了针对阿霉素的特异性抗体。以间马来酰亚胺苯甲酰-N-羟基琥珀酰亚胺酯(MBS)作为偶联剂制备了β-D-半乳糖苷酶标记的阿霉素。该测定系统采用双抗体固相法进行抗体结合型和游离型阿霉素的B/F分离。通过这种方法,可检测出0.5至100 ng的阿霉素。使用该测定系统,在以15 mg/kg腹腔注射单剂量阿霉素后,测定了小鼠血清中的药物水平,给药后20分钟出现峰值。发现血清水平的变化呈双相性,β相的半衰期约为5小时。